Cubist Pharmaceuticals Inc (CBST) Financial Statements (2024 and earlier)

Company Profile

Business Address 65 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments643,482566,011578,558921,185890,516852,511
Cash and cash equivalents221,838102,27791,058538,504205,43663,009
Short-term investments421,644463,734487,500382,681685,080789,502
Receivables107,395101,172123,155106,451101,60992,659
Inventory, net of allowances, customer advances and progress billings60,07957,97557,66355,07951,51343,286
Inventory60,07957,97557,66355,07951,51343,286
Prepaid expense and other current assets82,01651,47645,550
Deferred tax assets65,55684,57452,10838,38318,34317,935
Other undisclosed current assets64,11458,52558,285   
Total current assets:940,626868,257869,7691,203,1141,113,4571,051,941
Noncurrent Assets
Property, plant and equipment179,584176,963177,544170,122168,404166,272
Long-term investments and receivables    76,640110,08388,156
Long-term investments    76,640110,08388,156
Intangible assets, net (including goodwill)1,733,4011,087,8991,104,084410,983256,724261,906
Goodwill383,018383,018383,018273,572114,130114,130
Intangible assets, net (excluding goodwill)1,350,383704,881721,066137,411142,594147,776
Other noncurrent assets89,961102,91098,024   
Prepaid expense and other noncurrent assets73,67360,82664,496
Other undisclosed noncurrent assets237,400896,400896,400931,700272,700272,700
Total noncurrent assets:2,240,3462,264,1722,276,0521,663,118868,737853,530
TOTAL ASSETS:3,180,9723,132,4293,145,8212,866,2321,982,1941,905,471
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities256,757210,379276,955196,705188,030155,670
Accounts payable33,80136,86131,87736,06130,05432,227
Accrued liabilities222,956173,518245,078160,644157,976123,443
Other liabilities5,9596,3717,0343,5003,5003,500
Deferred revenue and credits6,7256,5456,4117,4175,9435,885
Other undisclosed current liabilities62,85862,06120,428 39,48738,987
Total current liabilities:332,299285,356310,828207,622236,960204,042
Noncurrent Liabilities
Long-term debt and lease obligation834,801826,2501,041,322809,539375,086371,418
Long-term debt, excluding current maturities834,801826,2501,041,322809,539375,086371,418
Liabilities, other than long-term debt441,401461,905436,938328,016171,495178,349
Deferred revenue and credits27,61029,80931,01031,95232,28233,579
Deferred tax liabilities, net363,358383,716357,802252,39894,48699,562
Liability for uncertainty in income taxes17,60016,40016,40015,90015,10015,400
Other liabilities32,83331,98031,72627,76629,62729,808
Other undisclosed noncurrent liabilities84,772111,543(36,998)145,472139,265136,879
Total noncurrent liabilities:1,360,9741,399,6981,441,2621,283,027685,846686,646
Total liabilities:1,693,2731,685,0541,752,0901,490,649922,806890,688
Equity
Equity, attributable to parent1,487,6991,447,3751,393,7311,375,5831,059,3881,014,783
Common stock767574746665
Additional paid in capital1,408,1411,391,6091,362,2401,338,259988,721958,892
Accumulated other comprehensive income (loss)1925621542(502)(35)
Retained earnings79,46355,43531,20237,20871,10355,861
Total equity:1,487,6991,447,3751,393,7311,375,5831,059,3881,014,783
TOTAL LIABILITIES AND EQUITY:3,180,9723,132,4293,145,8212,866,2321,982,1941,905,471

Income Statement (P&L) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues294,398261,233299,741265,993258,779229,929
Revenue, net(41,690)(41,306)(41,800)(24,993)(28,451)(28,421)
Cost of revenue
(Cost of Goods and Services Sold)
(88,613)(73,541)(80,605)(60,989)(63,041)(55,675)
Gross profit:205,785187,692219,136205,004195,738174,254
Operating expenses(205,888)(208,904)(305,951)(203,507)(170,279)(167,510)
Other undisclosed operating income42,27449,51871,3052,5592,6143,047
Operating income (loss):42,17128,306(15,510)4,05628,0739,791
Nonoperating expense(14,135)(14,087)(14,003)(43,171)(6,678)(6,202)
Other nonoperating income (expense)56(69)(113)(34,871)(146)240
Interest and debt expense(14,508)(14,395)(14,244)(8,924)(7,250)(7,184)
Other undisclosed income from continuing operations before equity method investments, income taxes  14,39514,2448,9247,2507,184
Income (loss) from continuing operations before equity method investments, income taxes:13,52814,219(29,513)(39,115)21,3953,589
Other undisclosed income from continuing operations before income taxes14,508     
Income (loss) from continuing operations before income taxes:28,03614,219(29,513)(39,115)21,3953,589
Income tax expense (benefit)(4,008)10,01423,5075,220(6,153)2,499
Income (loss) from continuing operations:24,02824,233(6,006)(33,895)15,2426,088
Income (loss) before gain (loss) on sale of properties:24,02824,233(6,006)(33,895)15,2426,088
Net income (loss) available to common stockholders, basic:24,02824,233(6,006)(33,895)15,2426,088
Other undisclosed net income available to common stockholders, diluted1,7551,854    
Net income (loss) available to common stockholders, diluted:25,78326,087(6,006)(33,895)15,2426,088

Comprehensive Income ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income (loss):24,02824,233(6,006)(33,895)15,2426,088
Comprehensive income (loss):24,02824,233(6,006)(33,895)15,2426,088
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(237)41173544(467)24
Comprehensive income (loss), net of tax, attributable to parent:23,79124,274(5,833)(33,351)14,7756,112

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: